tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

CRBU Stock Latest News

Caribou Biosciences Advances CAR-T Therapy Trials
Company AnnouncementsCaribou Biosciences Advances CAR-T Therapy Trials
5d ago
8K
CRBU
Caribou Biosciences initiates CB-010 GALLOP Phase 1 trial in lupus
PremiumThe Fly
Caribou Biosciences initiates CB-010 GALLOP Phase 1 trial in lupus
5d ago
CRBU
Caribou Biosciences price target lowered to $11 from $13 at BofA
PremiumThe Fly
Caribou Biosciences price target lowered to $11 from $13 at BofA
11d ago
CRBU
Caribou Biosciences price target raised to $34 from $26 at Brookline
PremiumThe Fly
Caribou Biosciences price target raised to $34 from $26 at Brookline
12d ago
CRBU
Caribou Biosciences Appoints New CFO Amid Clinical Advancements
PremiumCompany Announcements
Caribou Biosciences Appoints New CFO Amid Clinical Advancements
16d ago
8K
CRBU
Caribou Biosciences appoints Sri Ryali as CFO
PremiumThe FlyCaribou Biosciences appoints Sri Ryali as CFO
16d ago
CRBU
Shareholders of Caribou Biosciences, Inc. Should Contact Levi & Korsinsky LLP Before February 24, 2025 to Discuss Your Rights – CRBU
Premium
Class Action
Shareholders of Caribou Biosciences, Inc. Should Contact Levi & Korsinsky LLP Before February 24, 2025 to Discuss Your Rights – CRBU
22d ago
CRBU
Caribou (CRBU) Develops Transformative Cell Therapies and Captures Investors’ Attention
Premium
Market News
Caribou (CRBU) Develops Transformative Cell Therapies and Captures Investors’ Attention
1M ago
CRBU
Caribou Biosciences price target lowered to $6 from $30 at Citi
PremiumThe Fly
Caribou Biosciences price target lowered to $6 from $30 at Citi
2M ago
CRBU
Caribou Biosciences Reports Q3 2024 Financial Results
PremiumCompany Announcements
Caribou Biosciences Reports Q3 2024 Financial Results
2M ago
CRBU
Caribou Biosciences reports Q3 EPS (38c), consensus (45c)
PremiumThe Fly
Caribou Biosciences reports Q3 EPS (38c), consensus (45c)
2M ago
CRBU
Caribou Biosciences, Inc. (CRBU) Q3 Earnings Cheat Sheet
PremiumPre-Earnings
Caribou Biosciences, Inc. (CRBU) Q3 Earnings Cheat Sheet
3M ago
CRBU
Caribou Biosciences awarded EUR 1.6 million from France 2030
PremiumThe FlyCaribou Biosciences awarded EUR 1.6 million from France 2030
4M ago
CRBU
Vir Biotechnology appoints Jason O’Byrne as CFO
Premium
The Fly
Vir Biotechnology appoints Jason O’Byrne as CFO
4M ago
VIR
CRBU
Caribou treatment of acute myeloid leukemia designated for FDA orphan status
Premium
The Fly
Caribou treatment of acute myeloid leukemia designated for FDA orphan status
5M ago
CRBU
Caribou Biosciences Announces CFO Resignation and Succession Plan
PremiumCompany Announcements
Caribou Biosciences Announces CFO Resignation and Succession Plan
5M ago
8K
CRBU
Caribou Biosciences CFO Jason O’Byrne resigns
PremiumThe Fly
Caribou Biosciences CFO Jason O’Byrne resigns
5M ago
CRBU
Caribou Biosciences says FDA grants Fast Track designations to CB-010
PremiumThe Fly
Caribou Biosciences says FDA grants Fast Track designations to CB-010
5M ago
CRBU
Caribou Biosciences Ltp appoims Albertso as CMO
PremiumThe Fly
Caribou Biosciences Ltp appoims Albertso as CMO
5M ago
CRBU
LYEL
Caribou Biosciences reports Q2 EPS (42c), consensus (46c)
PremiumThe FlyCaribou Biosciences reports Q2 EPS (42c), consensus (46c)
5M ago
CRBU
Caribou Biosciences appoints Terri Laufer to Scientific Advisory Board
Premium
The Fly
Caribou Biosciences appoints Terri Laufer to Scientific Advisory Board
6M ago
CRBU
Caribou Biosciences price target lowered to $9 from $24 at H.C. Wainwright
Premium
The Fly
Caribou Biosciences price target lowered to $9 from $24 at H.C. Wainwright
8M ago
CRBU

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >